Correlation Between Aequus Pharmaceuticals and Nasdaq

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aequus Pharmaceuticals and Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aequus Pharmaceuticals and Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aequus Pharmaceuticals and Nasdaq Inc, you can compare the effects of market volatilities on Aequus Pharmaceuticals and Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aequus Pharmaceuticals with a short position of Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aequus Pharmaceuticals and Nasdaq.

Diversification Opportunities for Aequus Pharmaceuticals and Nasdaq

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aequus and Nasdaq is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Aequus Pharmaceuticals and Nasdaq Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nasdaq Inc and Aequus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aequus Pharmaceuticals are associated (or correlated) with Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nasdaq Inc has no effect on the direction of Aequus Pharmaceuticals i.e., Aequus Pharmaceuticals and Nasdaq go up and down completely randomly.

Pair Corralation between Aequus Pharmaceuticals and Nasdaq

Assuming the 90 days horizon Aequus Pharmaceuticals is expected to under-perform the Nasdaq. In addition to that, Aequus Pharmaceuticals is 7.97 times more volatile than Nasdaq Inc. It trades about -0.19 of its total potential returns per unit of risk. Nasdaq Inc is currently generating about 0.62 per unit of volatility. If you would invest  7,392  in Nasdaq Inc on September 1, 2024 and sell it today you would earn a total of  907.00  from holding Nasdaq Inc or generate 12.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Aequus Pharmaceuticals  vs.  Nasdaq Inc

 Performance 
       Timeline  
Aequus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Nasdaq Inc 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Nasdaq Inc are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Nasdaq reported solid returns over the last few months and may actually be approaching a breakup point.

Aequus Pharmaceuticals and Nasdaq Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aequus Pharmaceuticals and Nasdaq

The main advantage of trading using opposite Aequus Pharmaceuticals and Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aequus Pharmaceuticals position performs unexpectedly, Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nasdaq will offset losses from the drop in Nasdaq's long position.
The idea behind Aequus Pharmaceuticals and Nasdaq Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies